CompaniesByCap
NPCE
NeuroPace Inc. (NPCE)
NASDAQ · Healthcare

NeuroPace Inc. Revenue 2020–2025

NeuroPace Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • NeuroPace Inc. revenue for the quarter ending March 31, 2026 was 22.1 M, a 2.02% decrease year-over-year.
  • NeuroPace Inc. revenue for the twelve months ending March 31, 2026 was 95.5 M, a 27.51% increase year-over-year.
  • NeuroPace Inc. annual revenue for 2025 was 100.0 M, a 25.13% increase from 2024.
  • NeuroPace Inc. annual revenue for 2024 was 79.9 M, a 22.14% increase from 2023.
  • NeuroPace Inc. annual revenue for 2023 was 65.4 M, a 43.72% increase from 2022.
  • NeuroPace Inc. annual revenue for 2022 was 45.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

NeuroPace Inc. (NPCE) — Frequently Asked Questions

NeuroPace Inc. (NPCE) is a publicly traded US company. It has a market capitalization of $514M. In fiscal 2025 it reported revenue of $100M and net income of -$21M. Explore NPCE's stock price, financial statements, earnings history, margins and key ratios below.

What is NeuroPace Inc.'s market cap?

NeuroPace Inc. (NPCE) has a market capitalization of $514M.

What is the NPCE stock price?

NPCE trades at $15.72 (+0.06% on the day).

How much revenue does NeuroPace Inc. make?

NeuroPace Inc. reported revenue of $100M in fiscal 2025.

Is NPCE profitable?

In fiscal 2025, NeuroPace Inc. reported net income of -$21M.